alvarez BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) has made great progress in advancing its pipeline. That’s because it is currently evaluating the use of oral D Factor inhibitor, known as BCX10013, for the treatment of complemented mediated […]
Dovish pivot It finally looks like the Federal Reserve’s rate-hiking cycle has come to an end, as the central bank’s policymakers signaled that more rate cuts could be in store next year than they had […]
Andrew Burton I upgraded JD.com (NASDAQ:JD) to “Buy” in early October, saying that even with its struggles the stock had gotten too cheap and that its Logistics Unit was solid. Since then the stock has […]
© Copyright 2020-2023 Forex.ca
Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.